AI
TARO

Analytic Investors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Analytic Investors’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,368
Closed -$2.2M – 681
2016
Q1 		$2.2M Buy
+15,368
New +$2.18M 0.03% 299

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Analytic Investors's TARO Position: Q2 2016 in Review

Analytic Investors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 15,368 shares — an estimated $2.2M sold.

Analytic Investors first reported a position in TARO in Q1 2016 and held it in 1 quarter. The position peaked at $2.2M in Q1 2016. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

  • Analytic Investors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
  • Analytic Investors sold 15,368 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $2.2M.
  • Analytic Investors first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 1 quarter.
  • Analytic Investors's Taro Pharmaceutical Industries Ltd. position peaked at $2.2M in Q1 2016.
  • 159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Analytic Investors's 13F filing for Q2 2016, filed 11 Aug 2016.